CAR T Therapy Explained: A New Chapter in CLL Care
Join the HealthTree Foundation for this CAR T cell therapy-focused webinar for the CLL community. This is an excellent opportunity to learn more about this therapy class from an expert. There will be time for Q&A at the end of the event.
Dalton introduces the agenda of the event and our featured speaker Farrukh Awan, MD
Dr. Farrukh talks about CAR T Therapy for CLL patients
Type your questions in the chat and we will answer them!
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Farrukh Awan, MD
Farrukh Awan, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology at UTSW’s Harold C. Simmons Comprehensive Cancer Center, where he serves as the Associate Director of the Section of Hematologic Malignancies/Transplantation and Cellular Therapies and leads the Lymphoid Malignancies Program. He specializes in stem cell transplantation, cellular therapies, and the evaluation of novel therapies for patients with lymphoid malignancies, including chronic lymphocytic leukemia.